Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MXF Technologies is a medical technology company developing a novel molecular imaging platform based on Magnetic X-ray Fluorescence (MXF). The technology combines the high sensitivity of X-ray fluorescence with magnetic targeting to enable non-invasive, high-resolution imaging of biological targets at the molecular level. This platform is designed to improve the detection and monitoring of diseases such as cancer by providing deeper tissue penetration and lower background noise compared to traditional optical imaging. The company's goal is to bridge the gap between preclinical research and clinical diagnostics with a scalable, cost-effective imaging solution. By utilizing specific contrast agents, the MXF system can identify biomarkers with high precision, potentially transforming early-stage diagnosis and personalized medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MXF Technologies.